CXCR4, as the most common chemokine receptor, is responsible for numerous malignancies, including breast cancer, melanoma, prostate cancer, and GC (Lee et al., 2009; Fanelli et al., 2012). This evidence concerns the gene CXCR4 and prostate cancer.